Sign in
4

Changes in Ownership

Arcus Biosciences, Inc. Filed Acc 0001771961-26-000004

Chief Accounting Officer sold 2,562 shares at $25.77 ($66,024)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Azoy Alexander Chief Accounting Officer 2026-06-01 Sale 10b5-1 −2,562 $25.77 $66,024 39,581 D: show line 1 in the form
Open-market sales · 2,562 sh · avg $25.77 · $66,024
Loading xslF345X06/wk-form4_1780356235.xml…